Subclinical atherosclerosis: what it is, what it means and what we can do about it.
about
Chronic Inflammatory Diseases and Endothelial DysfunctionAtherosclerosis profile and incidence of cardiovascular events: a population-based survey.Metabolic syndrome criteria as predictors of subclinical atherosclerosis based on the coronary calcium score.Trends in the Levels of Serum Lipids and Lipoproteins and the Prevalence of Dyslipidemia in Adults with Newly Diagnosed Type 2 Diabetes in the Southwest Chinese Han Population during 2003-2012Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005Bone Mineral Density Is Positively Related to Carotid Intima-Media Thickness: Findings From a Population-Based Study in Adolescents and Premenopausal Women.Carotid intima-media thickness in children with CKD: results from the CKiD study.Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome.Screening for subclinical atherosclerosis by noninvasive methods in asymptomatic patients with risk factorsEarly Markers of Atherosclerotic Disease in Individuals with Excess Weight and Dyslipidemia.Bone marrow-derived and peritoneal macrophages have different inflammatory response to oxLDL and M1/M2 marker expression - implications for atherosclerosis research.The association between "hypertriglyceridemic waist" and sub-clinical atherosclerosis in a multiethnic population: a cross-sectional studyCoronary Artery Calcium and Carotid Artery Intima Media Thickness and Plaque: Clinical Use in Need of Clarification.Imaging subclinical atherosclerosis: is it ready for prime time? A review.A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection.Detection of incidental cardiac findings in noncardiac chest computed tomography.Lipid Lowering Effect of Punica granatum L. Peel in High Lipid Diet Fed Male Rats.Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis.Association of change in waist circumference and dyslipidemia risk: The Rural Chinese Cohort Study.High prevalence of subclinical atherosclerosis in Brazilian postmenopausal women with low and intermediate risk by Framingham score.Antidepressant Use and Subclinical Measures of Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis.Soluble intracellular adhesion molecule-1 and omentin-1 as potential biomarkers of subclinical atherosclerosis in hemodialysis patients.Association of magnesium in serum and urine with carotid intima-media thickness and serum lipids in middle-aged and elderly Chinese: a community-based cross-sectional study.Trends in lipid profiles among South Korean adults: 2005, 2008 and 2010 Korea National Health and Nutrition Examination Survey.Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.Subclinical Atherosclerosis Among Young and Middle-Aged Adults Using Carotid Intima-Media Thickness Measurements.Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs.Relationship between Framingham risk score and subclinical atherosclerosis in carotid plaques: an in vivo study using multi-contrast MRI.Extracellular Vesicles Work as a Functional Inflammatory Mediator Between Vascular Endothelial Cells and Immune Cells
P2860
Q26774158-8367009B-ABCC-4DE9-8CB7-79E75F2189D1Q33503404-34D17456-8BE7-4636-B000-FE0D0BA93191Q34948205-9ED1AE9F-E3FC-4317-A981-C61F5527EE95Q35671301-E3F5F61C-1206-4AA6-9544-F3B517D0E47DQ35770047-C6898CDA-0E4A-4368-9C60-AE0ECFA106A9Q36064257-AB7B8394-6FE6-4D51-95D3-A9371857759AQ36443220-2CD337D2-B1E9-429D-BD66-33089633E290Q36886436-60AAC6C0-7152-4445-95D6-EBCAD3561140Q36905813-68505DEC-C638-45C5-9B85-BCF0B9655962Q37083186-C1E76048-F290-4F2B-91F7-9729F1CF0810Q37335911-BF07B94A-5E38-4472-9008-A9B6E7318D84Q37609267-1A2B7808-8A1A-4C3E-93F8-F088AEB51C53Q37740344-819C81FA-F740-4F35-ADD4-7D1037CCEBF0Q38239604-DFBCB8A8-6DC0-47D2-83BA-32F0F82F1C69Q38314236-245875A2-AE00-405B-A5A2-D28EF14FE69EQ38672002-03DED29D-AEE8-43DE-BB25-D169EC6542FAQ39116983-FF572BAC-41A4-4C29-A0B1-D93E7F5A1B6BQ39267608-523608C8-9336-498E-97AF-02E70CDC057DQ40050508-6FBDF1ED-BC7D-4850-969F-C6EEB051A016Q40527056-D56E23F5-32BA-41A5-8B2A-484A14BB9F5AQ40715268-E72570B8-8F78-42CC-A9B2-CEBE02FFB62AQ40829122-D2F83C5A-1F9F-4C2F-BE51-543730A9134CQ41271005-F9DF7DC4-52D8-41FA-94AD-B6E913C1E712Q44190015-A7A740FA-7590-4D69-B308-C0DBC0CCFAA0Q46590378-00F5736A-E775-4E10-BC10-DD14B31421B4Q47662687-C567558E-0C09-44C9-947F-A167DD56FF8CQ48526234-BEEFCA0B-7812-4DD4-B40A-821FA29D4F1FQ52927853-ED121913-4D03-406A-8BC7-20A0E2B40A43Q58798796-0F721C4E-1ABA-4407-8CBC-267B5E3AA976
P2860
Subclinical atherosclerosis: what it is, what it means and what we can do about it.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Subclinical atherosclerosis: what it is, what it means and what we can do about it.
@en
Subclinical atherosclerosis: what it is, what it means and what we can do about it.
@nl
type
label
Subclinical atherosclerosis: what it is, what it means and what we can do about it.
@en
Subclinical atherosclerosis: what it is, what it means and what we can do about it.
@nl
prefLabel
Subclinical atherosclerosis: what it is, what it means and what we can do about it.
@en
Subclinical atherosclerosis: what it is, what it means and what we can do about it.
@nl
P2860
P1476
Subclinical atherosclerosis: what it is, what it means and what we can do about it.
@en
P2093
P2860
P304
P356
10.1111/J.1742-1241.2008.01804.X
P5008
P577
2008-06-28T00:00:00Z
2008-08-01T00:00:00Z